S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

PIRS Pieris Pharmaceuticals Inc

10.15

0.00 (0.00%)

Pre Market

Last Updated: 03:33:39

Delayed by 15 minutes

Annual Report to Security Holders (ars)

This regulatory filing also includes additional resources:
formars2.pdf

Pieris Pharmaceuticals (NASDAQ:PIRS)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Pieris Pharmaceuticals Charts.

Pieris Pharmaceuticals (NASDAQ:PIRS)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Pieris Pharmaceuticals Charts.

Pieris Pharmaceuticals, Inc. News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 15 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (4 weeks ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (4 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Friday 2 February 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 21 December 2023 (5 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 14 November 2023 (7 months ago) • Edgar (US Regulatory)

Form 8-K/A - Current report: [Amend]
Thursday 31 August 2023 (9 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Thursday 10 August 2023 (10 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 10 August 2023 (10 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 18 July 2023 (11 months ago) • Edgar (US Regulatory)

More Pieris Pharmaceuticals, Inc. News Articles

Stedin Holding NV 0.5% u...

Victory Partners VIII No... (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions